Keyphrases
Coronary Artery Disease
89%
Acute Coronary Syndrome
85%
Acute Myocardial Infarction
81%
Peroxisome Proliferator-activated Receptor
77%
Genotype
71%
Polymorphism
68%
Hypertrophic Cardiomyopathy
61%
Heart Failure
58%
Myocardial Infarction
57%
Confidence Interval
56%
Cardiovascular Disease
47%
Beta-blockers
46%
Medium-chain acyl-CoA Dehydrogenase
41%
Pharmacogenetics
38%
African American
34%
Hypertrophic Obstructive Cardiomyopathy
33%
Hazard Ratio
30%
Single nucleotide Polymorphism
30%
Nuclear Receptor
27%
Genetic Variants
25%
Angina
25%
Estrogen Receptor
25%
Type 2 Diabetes Mellitus (T2DM)
25%
CHRNA5
25%
Genome-wide Association Study
23%
Coactivator
23%
Gene Polymorphism
22%
Revascularization
21%
Transcription Factor
20%
Nuclear Receptor Activation
20%
Response Element
20%
Subsequent Events
19%
Event Risk
18%
White People
17%
Receptor Gene
17%
SNP
17%
Individual Participant Data
16%
Precision Medicine
16%
Clinical Outcomes
16%
United States
16%
Adjusted Odds Ratio
16%
Mavacamten
16%
Inequity
16%
Scientific Statement
16%
Chromosome 9p21
16%
Pathway Genes
16%
Angioplasty
16%
Gene Variants
16%
Clopidogrel
16%
Transgenic Mice
15%
Biochemistry, Genetics and Molecular Biology
Genotyping
100%
Genetics
79%
Allele
46%
Genetic Divergence
44%
Medium-Chain Acyl-CoA Dehydrogenase
41%
Acyl-CoA
41%
Single-Nucleotide Polymorphism
40%
Nuclear Receptor
38%
Peroxisome Proliferator-Activated Receptor
37%
Genome-Wide Association Study
32%
Promoter Region
30%
Genomics
25%
Pharmacogenetics
24%
Single Nucleotide Polymorphism
24%
Oxidoreductase
20%
Blood Plasma
19%
Beta Oxidation
19%
Adrenergic Receptor
18%
Low-Density Lipoprotein
18%
Pharmacogenomics
17%
Response Element
17%
Estrogen-Related Receptor
16%
Exome Sequencing
16%
CHRNA5
16%
Enzyme
16%
Transgenic Mouse
16%
Gene Expression
16%
Skeletal Muscle
16%
Clinical Trial
15%
Candidate Gene
15%
Transactivation
14%
Gene Promoter
13%
MMP3
12%
Dehydrogenase
12%
Nuclear Gene
12%
Gene Polymorphism
11%
GRK5
11%
Binding Site
11%
Coenzyme A
11%
Lipid
11%
Homozygote
11%
Messenger RNA
10%
Genetic Variation
9%
All Cause Mortality
9%
Gene Locus
9%
Locus Control Region
9%
Intron
9%
Fenofibrate
8%
Genetic Association Study
8%
Plasminogen Activator Inhibitor-1
8%
Medicine and Dentistry
Hypertrophic Cardiomyopathy
63%
Congestive Heart Failure
49%
Acute Coronary Syndrome
37%
Coronary Artery Disease
30%
Cardiovascular Disease
26%
Hypertrophic Obstructive Cardiomyopathy
25%
Peroxisome Proliferator Activated Receptor
25%
Odds Ratio
23%
Acute Heart Infarction
22%
Personalized Medicine
21%
Hazard Ratio
20%
DNA Polymorphism
19%
Diabetes
18%
Mavacamten
16%
Myocardial Infarction
16%
Diseases
15%
Adrenergic Receptor
15%
Receptor
14%
Obstruction
14%
Single Nucleotide Polymorphism
12%
Clinical Trial
12%
Prospective Cohort Study
12%
Diabetes Mellitus
11%
Pharmacogenetics
11%
Myocardial Disease
11%
Placebo
10%
Heart Transplantation
10%
Post-Hoc Analysis
9%
Heart Left Ventricle Outflow Tract Obstruction
9%
Revascularization
9%
Atherosclerosis
9%
Allele
8%
Quality of Life
8%
Ischemic Heart Disease
8%
Clinician
8%
COVID-19
8%
Middle Age
8%
Heart Atrium Function
8%
Long Term Survival
8%
Echocardiography
8%
Downregulation
8%
Angina pectoris
8%
Genetic Research
8%
Cardiogenic Shock
8%
Aromatase
8%
Insulin Resistance
8%
Takotsubo Cardiomyopathy
8%
Interventricular Septum
8%
Angioplasty
8%
Exercise Test
8%